European Society of Cardiology

Medications

Milvexian shows potential to reduce risk of ischemic stroke

A phase 2 trial in patients with a prior ischemic stroke or high-risk transient ischemic attack (TIA) has indicated that milvexian should be further investigated for its ability to reduce the risk of ischemic stroke without ...

Medications

New anticoagulant may prevent recurrent ischemic stroke

The PACIFIC-Stroke trial has failed to reach its primary endpoint but in an exploratory analysis, inhibition of factor XIa with asundexian reduced recurrent ischemic stroke and transient ischemic attack (TIA) without increasing ...

page 12 from 40